Myopia Management Clinic
Myopia (short‑sightedness) can worsen as children grow. A dedicated myopia assessment helps us understand progression risk and discuss suitable management options to help slow it down.
We can discuss options such as MiSight 1 day contact lenses, Stellest spectacle lenses and low‑dose atropine, and help you decide what is appropriate for your child.
Management plans focus on long‑term eye health, balancing clear vision with options that aim to slow progression.
Why myopia management matters
Myopia is more than needing glasses. It develops because the eye grows too long, and the higher a child’s prescription becomes, the greater their lifetime risk of eye conditions such as retinal detachment, myopic maculopathy, glaucoma and early cataract.
Research led by the Brien Holden Vision Institute projects that around half the world’s population — nearly 5 billion people — will be short‑sighted by 2050, with about 1 billion at higher risk of sight loss from high myopia. The rise is linked mainly to less time outdoors and more close‑up work.
Because of this, professional bodies including the College of Optometrists and the Association of Optometrists support proactive myopia management for children whose short‑sightedness is progressing, rather than simply updating glasses each year. Evidence summarised by the International Myopia Institute also shows that spending around two hours a day outdoors helps reduce the onset and progression of myopia.
References: Brien Holden Vision Institute, International Myopia Institute, College of Optometrists, Association of Optometrists.
Stellest lenses
Stellest lenses are spectacle lenses designed for myopic children, using Essilor’s H.A.L.T. technology — a constellation of 1,021 aspherical lenslets arranged in rings that help slow the eye’s elongation while correcting vision. We can explain whether they are suitable based on your child’s assessment.
Stellest clinical highlights
On average, Stellest lenses slowed myopia progression by 67% compared with single‑vision lenses when worn at least 12 hours a day, over a 2‑year clinical trial.
100% of children adapted to Stellest lenses within one week of wear.
Source: Essilor Stellest clinical data.
MiSight 1 day
MiSight 1 day is a daily disposable contact lens designed to slow the worsening of myopia in children, with fitting and aftercare support.
CooperVision notes MiSight 1 day is proven to slow the worsening of myopia by about 50% in clinical studies, with daily replacement wear.
Learn about MiSight 1 dayLow‑dose atropine
Low‑dose atropine is a nightly eye drop used to help slow myopia progression in children. It can be used on its own or alongside myopia management lenses, where clinically appropriate. We will discuss whether it is a suitable option as part of your child’s plan.
What to expect
- Assessment of current prescription and vision needs.
- Discussion of lifestyle and progression risk factors.
- Explanation of management options and follow‑up plan.
Care and follow‑up
- Regular reviews to monitor progression.
- Clear guidance on lens wear and care.
- Adjustments based on your child’s response.
Management options
- Specialist spectacle lenses (e.g., Stellest).
- Daily disposable myopia control lenses (e.g., MiSight 1 day).
- Low‑dose atropine eye drops, where clinically appropriate.
- Advice on screen habits and outdoor time.
Facts & figures
- Around half the world’s population is projected to be short‑sighted by 2050, with about 1 billion at higher risk of sight loss from high myopia (Brien Holden Vision Institute).
- Spending around two hours a day outdoors helps reduce the onset and progression of myopia (International Myopia Institute).
- CooperVision reports an average slowing of myopia progression by about 50% in clinical studies of MiSight 1 day.
- Essilor reports Stellest lenses slowed myopia progression by 67% on average vs single‑vision lenses when worn at least 12 hours a day over a 2‑year trial, with 100% of children adapting within one week.
Sources: MiSight 1 day, Stellest, Brien Holden Vision Institute.